These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31346805)

  • 1. The use of a proposed updated EARL harmonization of
    Ly J; Minarik D; Edenbrandt L; Wollmer P; Trägårdh E
    EJNMMI Res; 2019 Jul; 9(1):65. PubMed ID: 31346805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
    Enilorac B; Lasnon C; Nganoa C; Fruchart C; Gac AC; Damaj G; Aide N
    J Nucl Med; 2018 Jul; 59(7):1049-1055. PubMed ID: 29242403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variation of quantitative parameters and Deauville scores with different reconstruction algorithms in FDG PET/CT imaging of lymphoma patients.
    Genc M; Yildirim N; Coskun N; Ozdemir E; Turkolmez S
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):388-392. PubMed ID: 37524200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
    Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
    Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
    van Sluis J; van Snick JH; Brouwers AH; Noordzij W; Dierckx RAJO; Borra RJH; Slart RHJA; Lammertsma AA; Glaudemans AWJM; Boellaard R; Tsoumpas C
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4652-4660. PubMed ID: 35876867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
    Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Often Do We Fail to Classify the Treatment Response with [
    Mattoli MV; Calcagni ML; Taralli S; Indovina L; Spottiswoode BS; Giordano A
    Mol Imaging Biol; 2019 Dec; 21(6):1210-1219. PubMed ID: 30850971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-automated
    Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
    Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of alteration in liver
    Salomon T; Nganoa C; Gac AC; Fruchart C; Damaj G; Aide N; Lasnon C
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):941-950. PubMed ID: 29279943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of acquisition time and penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm on a Si-photomultiplier-based PET-CT system for
    Trägårdh E; Minarik D; Almquist H; Bitzén U; Garpered S; Hvittfelt E; Olsson B; Oddstig J
    EJNMMI Res; 2019 Jul; 9(1):64. PubMed ID: 31342214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.
    Aide N; Lasnon C; Veit-Haibach P; Sera T; Sattler B; Boellaard R
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):17-31. PubMed ID: 28623376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and clinical implications of the EARL2 versus EARL1 [
    Cox MC; Jurcka T; Arens AIJ; van Rijk MC; Kaanders JHAM; van den Bosch S
    EJNMMI Res; 2023 Oct; 13(1):91. PubMed ID: 37878160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.
    Kaalep A; Sera T; Oyen W; Krause BJ; Chiti A; Liu Y; Boellaard R
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):412-422. PubMed ID: 29192365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUV Harmonization Between Different Hybrid PET/CT Systems.
    Rubello D; Colletti PM
    Clin Nucl Med; 2018 Nov; 43(11):811-814. PubMed ID: 30199381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
    Biggi A; Bergesio F; Chauvie S; Bianchi A; Menga M; Fallanca F; Hutchings M; Gregianin M; Meignan M; Gallamini A
    Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):410-415. PubMed ID: 28750493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis imaging study using interim [
    Tonnelet D; Bohn MDP; Becker S; Decazes P; Camus V; Thureau S; Tilly H; Jardin F; Vera P
    EJNMMI Res; 2021 Apr; 11(1):37. PubMed ID: 33846870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
    Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
    Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
    Khong PL; Huang B; Lee EY; Chan WK; Kwong YL
    J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting detection of in-transit metastases in melanoma patients using digital
    Zimmermann PA; Houdu B; Césaire L; Nakouri I; De Pontville M; Lasnon C; Aide N
    Ann Nucl Med; 2021 Jun; 35(6):669-679. PubMed ID: 33770374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.